Covered recipient · General Payments record
TEHSEEN FAZILI KHAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$5,433.66
- Reported across 360 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,010.79 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $310.67 | 19 |
| UCB, Inc. | $175.97 | 10 |
| LivaNova USA, Inc. | $169.92 | 4 |
| Abbott Laboratories | $76.05 | 4 |
| Lundbeck LLC | $54.33 | 3 |
| EISAI INC. | $49.68 | 2 |
| Biogen, Inc. | $39.90 | 2 |
| SK Life Science, Inc. | $30.37 | 2 |
| Azurity Pharmaceuticals, Inc. | $23.21 | 1 |
| Neurocrine BioSciences, Inc. | $19.59 | 1 |
| Celgene Corporation | $17.44 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.25 | 1 |
| Lilly USA, LLC | $13.32 | 1 |
| PFIZER INC. | $13.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.38 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124809871 | CMS |
| Abbott Laboratories | $13.70 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124809873 | CMS |
| Abbott Laboratories | $18.52 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124809875 | CMS |
| Abbott Laboratories | $24.45 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124809877 | CMS |
| ABBVIE INC. | $19.96 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716065 | CMS |
| ABBVIE INC. | $9.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716067 | CMS |
| ABBVIE INC. | $15.66 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716069 | CMS |
| ABBVIE INC. | $14.87 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716071 | CMS |
| ABBVIE INC. | $13.41 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716073 | CMS |
| ABBVIE INC. | $19.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716075 | CMS |
| ABBVIE INC. | $21.73 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716077 | CMS |
| ABBVIE INC. | $10.64 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716079 | CMS |
| ABBVIE INC. | $16.77 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716081 | CMS |
| ABBVIE INC. | $20.74 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716083 | CMS |
| ABBVIE INC. | $13.85 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716085 | CMS |
| ABBVIE INC. | $15.43 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716087 | CMS |
| ABBVIE INC. | $22.71 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716089 | CMS |
| ABBVIE INC. | $17.18 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716091 | CMS |
| ABBVIE INC. | $12.98 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716093 | CMS |
| ABBVIE INC. | $16.65 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716095 | CMS |
| ABBVIE INC. | $20.97 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716097 | CMS |
| ABBVIE INC. | $14.94 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716099 | CMS |
| ABBVIE INC. | $12.98 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716101 | CMS |
| Azurity Pharmaceuticals, Inc. | $23.21 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134005585 | CMS |
| Biogen, Inc. | $15.76 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104806489 | CMS |
| Biogen, Inc. | $24.14 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104831172 | CMS |
| Celgene Corporation | $17.44 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101087655 | CMS |
| Eisai Inc. | $24.24 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785027 | CMS |
| Eisai Inc. | $25.44 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785025 | CMS |
| Lilly USA, LLC | $13.32 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135459980 | CMS |
| LivaNova USA, Inc. | $44.32 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790307 | CMS |
| LivaNova USA, Inc. | $46.56 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790385 | CMS |
| LivaNova USA, Inc. | $42.60 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790387 | CMS |
| LivaNova USA, Inc. | $36.44 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790409 | CMS |
| Lundbeck LLC | $20.76 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914879 | CMS |
| Lundbeck LLC | $17.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914881 | CMS |
| Lundbeck LLC | $16.05 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914883 | CMS |
| Neurocrine Biosciences, Inc. | $19.59 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150860463 | CMS |
| PFIZER INC. | $13.09 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131437079 | CMS |
| SK Life Science, Inc. | $14.57 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154147564 | CMS |
| SK Life Science, Inc. | $15.80 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154147634 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.25 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151599439 | CMS |
| UCB, Inc. | $12.35 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408389 | CMS |
| UCB, Inc. | $15.52 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408394 | CMS |
| UCB, Inc. | $1.67 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408398 | CMS |
| UCB, Inc. | $18.57 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408403 | CMS |
| UCB, Inc. | $19.21 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408421 | CMS |
| UCB, Inc. | $18.74 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408425 | CMS |
| UCB, Inc. | $24.71 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408430 | CMS |
| UCB, Inc. | $25.02 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408434 | CMS |
| UCB, Inc. | $15.89 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408439 | CMS |
| UCB, Inc. | $24.29 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143408443 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.